Fresenius Medical Care Shares Retreat After CMS Proposal and Lingering Analyst Cautions
Fresenius Medical Care stock slid about 4.6% to €40.21, surrendering much of the gains it had earned in a strong rally the prior week. The fall follows a U.S. Centers for Medicare & Medicaid Services (CMS) proposal that included a smaller-than-expected 1.1% increase to the end-stage renal disease bundle base rate and a plan to fold phosphate binder…